The good news is “yes, you can stay on-budget!“. The “Plan A” is an analytical approach to cost-effective Risk Based Budgeting (RBB). Authors Igor Stefanov, CEO Synergy Research Group, and Artem Andrianov, CEO Cyntegrity, explain how understanding, quantifying and mitigating risks that may impact clinical outcomes can lead to an overall cost reduction of 2%. Read how RBB can help you keeping your clinical trial on-budget.
About the Author: Linda Bunschoten - Chief Marketing Officer
Linda has 25+ years of experience uncovering pain points and strategizing with companies in the healthcare industry in order to secure and retain more clients. Her chief thinking responsibilities include translating insight into strategy and ensure that all MarCom and Product Management activities contribute to our overall customer experience and meet our industry’s quality expectations.